PARACLINICAL AND HISTOPATHOLOGICAL FEATURES OF STEATOHEPATITIC HEPATOCELLULAR CARCINOMA
Main Article Content
Abstract
Objective: Determine the prevalence of Steatohepatitic HCC subtype in Vietnamese patients and the role of this subtype in the prognosis of early recurrence. Materials and Methods: From 108 patients undergoing hepatectomy due to HCC at the University Medical Center Ho Chi Minh City in 2018, cases diagnosed as SH-HCC and C-HCC were selected. We compared the clinical characteristics, histopathological characteristics of tumor liver tissue and background liver tissue, CK19 expression, and TERT promoter mutation status and compared the early recurrence rate between the SH-HCC and C-HCC groups. Results: SH-HCC accounts for 15.7% of all HCC subtypes. The SH-HCC subtype tends to have less tumor necrosis and microscopic vascular invasion, as well as the underlying liver tissue has a higher degree of fatty degeneration than the C-HCC group. There is no difference in the rate of early tumor recurrence between the 2 groups. However, SH-HCC tumors with microscopic vascular invasion will have a significantly higher early recurrence rate than the C-HCC group. Conclusion: SH-HCC is the second most common subtype among all HCC cases with a rate of 15.7%. The risk of early recurrence between SH–HCC and C–HCC subtypes is not different.
Article Details
Keywords
Steatohepatitic hepatocellular carcinoma, early recurrent rate, histopathology
References
2. Chan A. W., Yu S., et al. (2016). "Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse". Histopathology. 69 (6), pp. 971-984.
3. Lokuhetty Dilani, White Valerie A., et al. (2019). "Digestive system tumours". International Agency for Research on Cancer Lyon Lyon, pp. xi, 635 pages : color illustrations ; 27 cm.
4. Salomao M., Remotti H., et al. (2012). "The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis". Hum Pathol. 43 (5), pp. 737-46.
5. Salomao M., Yu W. M., et al. (2010). "Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD /NASH". Am J Surg Pathol. 34 (11), pp. 1630-6.
6. Shin S. H., Park J. Y., et al. (2023). "Histological subtypes of hepatocellular carcinoma: Their clinical and prognostic significance". Ann Diagn Pathol. 64, pp. 152134.
7. Shibahara Junji, Ando Sumiyo, et al. (2014). "Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients". Histopathology. 64 (7), pp. 951-962.
8. Sun Li-Yang, Wang Nan-Ya, et al. (2023). "Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score". Hepatobiliary & Pancreatic Diseases International. pp.
9. Sweed Dina, Sweed Enas, et al. (2022). "The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt". World Journal of Surgical Oncology. 20 (1), pp. 298.
10. Torbenson Michael S. and Yeh Mathew M. %J Hepatoma Research (2021). "Steatohepatitic hepatocellular carcinoma". 7, pp.